A.J. van den Eertwegh

Clinical, Endoscopic, and Histologic Characteristics of Ipilimumab-Associated Colitis

Eduard Cornelis Verschuren, A.J. van den Eertwegh, Janneke Wonders et al. · Clinical Gastroenterology and Hepatology · 2015 · 142 citations

Gastroenterology, Pathology, Gi Technique +4

Brain Metastases in Patients With Renal Cell Cancer Receiving New Targeted Treatment

Helgi H. Helgason, Henk Mallo, Helga Droogendijk et al. · Journal of Clinical Oncology · 2007 · 42 citations · Full text

Neuro-oncology, Urology, Brain Metastases +5

Health-related quality of life of long-term advanced melanoma survivors treated with anti-CTLA-4 immune checkpoint inhibition compared to matched controls

Annelies H. Boekhout, Anne Rogiers, Katarzyna Jóźwiak et al. · Acta Oncologica · 2020 · 30 citations · Full text

Real-world Data of Nivolumab for Patients With Advanced Renal Cell Carcinoma in the Netherlands: An Analysis of Toxicity, Efficacy, and Predictive Markers

Saskia Lisa Verhaart, Yasmin Abu‐Ghanem, Sasja F. Mulder et al. · Clinical Genitourinary Cancer · 2020 · 21 citations · Full text

Urology, Renal Function, Predictive Markers +7

Updated Overall Survival (Os) from the Phase 3 Trial, Ca184-043: Ipilimumab (Ipi) Vs Placebo (Pbo) in Patients with Post-Docetaxel Metastatic Castration-Resistant Prostate Cancer (Mcrpc)

Karim Fizazi, Charles G. Drake, E.D. Kwon et al. · Annals of Oncology · 2014 · 11 citations

Urology, Oncology, Genitourinary Cancer +8